Skip to main content
MDxHealth SA logo

MDxHealth SA — Investor Relations & Filings

Ticker · MDXH ISIN · BE0974461940 LEI · 549300J3MG9F9B5FY646 BR Human health and social work activities
Filings indexed 940 across all filing types
Latest filing 2024-09-30 Capital/Financing Update
Country BE Belgium
Listing BR MDXH

About MDxHealth SA

https://mdxhealth.com/

MDxHealth SA is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize the diagnosis and treatment of urologic conditions. The company's portfolio of tests is designed to assist clinicians in making more informed decisions. For prostate cancer, its products include Select mdx, which assesses a patient's risk to help determine if a biopsy can be safely avoided; Confirm mdx, which addresses biopsy sampling errors; and the GPS (Genomic Prostate Score) test, a genomic assay that helps guide treatment decisions for men with localized disease. Additionally, the company offers Resolve mdx, a test that aids in selecting appropriate treatment for patients presenting with symptoms of urinary tract infections (UTIs).

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Capital/Financing Update Classification · 100% confidence The document is a Form 6-K filed by a foreign private issuer, MDxHealth SA, with the SEC. It reports on a recent capital raising event including an underwriting agreement, securities purchase agreement, and an amendment to the Articles of Association to reflect a capital increase. The document includes exhibits related to the underwriting and securities purchase agreements, legal opinions, and press releases. The content focuses on financing activities and capital structure changes, specifically the issuance and sale of new ordinary shares and related agreements. There is no detailed financial report or earnings data, but rather an update on capital raising and related corporate actions. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is sufficient and the content is substantive, not merely an announcement or a certification, supporting a high confidence classification as CAP.
2024-09-30 English
PROSPECTUS
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a public offering of ordinary shares by MDxHealth SA. It includes detailed information about the offering, underwriting, risk factors, use of proceeds, and other related disclosures. This type of document is a capital raising disclosure that updates and supplements a base prospectus and is used to inform investors about the terms of a securities offering. It is not a financial report, earnings release, or management discussion, nor is it a regulatory filing unrelated to capital markets. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering terms, underwriting details, and risk disclosures typical of a prospectus supplement for a share offering.
2024-09-26 English
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a public offering of ordinary shares by MDxHealth SA. It includes detailed information about the offering, underwriting, risk factors, use of proceeds, and other related disclosures typical of a capital raising document. The presence of terms like "Prospectus Supplement," "Offering," "Underwriting," and references to the Securities and Exchange Commission (SEC) registration and rules indicate this is a capital/financing update document. It is not an annual report, earnings release, or any other type of report but specifically a document related to a securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the actual offering document, not just an announcement or notice.
2024-09-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by a foreign private issuer, MDxHealth SA, submitted to the SEC. It includes multiple exhibits: an interim report (Exhibit 99.1), a press release (Exhibit 99.2), and amendments to a credit agreement (Exhibits 4.1 and 4.2). The document itself is a report of foreign private issuer pursuant to SEC rules, and the main substantive financial document referenced is the 2024 Interim Report attached as an exhibit. The document length is 3664 characters, which is relatively short and mostly serves as a cover/reporting form with attachments. According to the "Menu vs Meal" rule, since this document states that the interim report is attached as an exhibit and the document itself is a Form 6-K filing (which is a regulatory filing to report material information by foreign private issuers), the classification should be Regulatory Filings (RNS). The actual interim report is an exhibit and not the main document text here. Therefore, the document is best classified as Regulatory Filings (RNS).
2024-08-21 English
Regulatory Filings 2024
Regulatory Filings
2024-07-11 English
Regulatory Filings 2024
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Securities and Exchange Commission (SEC) regarding a Registration Statement on Form F-3. It requests acceleration of the effective date for the registration statement under the Securities Act of 1933. The content is a formal correspondence related to a regulatory filing process, specifically about the registration statement effectiveness, not the registration statement itself or any financial data. The document length is short (1416 characters), and it is a request letter, not a report or financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-07-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.